NFкB pathway suppression as a key driver of pacritinib response in high‐risk myelofibrosis
R. Van Dijck, M. ter Borg, B. van der Holt, A. E. C. Broers, M. D. Hazenberg, J. J. Cornelissen, N. P. M. Schaap, E. de Pater, P. A. W. te Boekhorst British Journal of Haematology
· Wiley
· 2026-11-10
· DOI: 10.1111/bjh.70811
The publisher did not provide an abstract — full text is available via the link below.
R. Van Dijck, M. ter Borg, B. van der Holt, A. E. C. Broers, M. D. Hazenberg, J. J. Cornelissen et al. NFкB pathway suppression as a key driver of pacritinib response in high‐risk myelofibrosis. // British Journal of Haematology. – 2026. – DOI: 10.1111/bjh.70811. – URL: https://onlinelibrary.wiley.com/doi/10.1111/bjh.70811?af=R
R. Van Dijck, M. ter Borg, B. van der Holt, A. E. C. Broers, M. D. Hazenberg, J. J. Cornelissen, N. P. M. Schaap, E. de Pater, & P. A. W. te Boekhorst (2026). NFкB pathway suppression as a key driver of pacritinib response in high‐risk myelofibrosis. British Journal of Haematology. https://doi.org/10.1111/bjh.70811
R. Van Dijck, et al. “NFкB pathway suppression as a key driver of pacritinib response in high‐risk myelofibrosis.” British Journal of Haematology, 2026. doi:10.1111/bjh.70811.
@article{Dijck2026,
title = {NFкB pathway suppression as a key driver of pacritinib response in high‐risk myelofibrosis},
author = {Dijck, R. Van and Borg, M. ter and Holt, B. van der and Broers, A. E. C. and Hazenberg, M. D. and Cornelissen, J. J. and Schaap, N. P. M. and Pater, E. de and Boekhorst, P. A. W. te},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70811},
url = {https://onlinelibrary.wiley.com/doi/10.1111/bjh.70811?af=R}
}